Researchers at the University of Rochester are working on a method for rapid cancer diagnosis using SiMPore’s ultrathin nanomembranes. This technique, known as catch and display for liquid biopsies (CAD-LB), captures extracellular vesicles (EVs)—nano-sized carriers of cellular information—from minimally processed blood samples.
By fluorescently labeling EVs caught in the membranes’ nanopores, CAD-LB enables quick detection of cancer biomarkers and immune-modulatory proteins, supporting early diagnosis and tailored immunotherapies.
“CAD-LB is faster and simpler, making it ideal for clinical use,” says James McGrath, lead researcher and SiMPore co-founder.